Diabetes & Endocrinology
436 - 450 of
1033 Results
Sort Results:
Article:
Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes
August 2013
Article:
Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge
July 2013
Guideline:
Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013)
June 2013